This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase II trial to assess the safety, immunologic...
Clinical trial

A phase II trial to assess the safety, immunological activity of Trovax plus Pemetrexed/ Cisplatin in patients with malignant pleural mesothelioma.

Read time: 1 mins
Last updated:21st Mar 2011
To evaluate whether TroVax� is active in the treatment of MPM. This will be assessed by measuring the cellular or humoral anti-5T4 immune responses following treatment with TroVax� given in combination with Pem/Cis.
Category Value
Study start date 2011-03-21

View full details